Back to search
Seasonal Allergic Rhinitis (SAR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Seasonal Allergic Rhinitis (SAR) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Seasonal Allergic Rhinitis (SAR) trials you may qualify forThis study aims to evaluate the effectiveness and safety of ALDP001 Nasal Spray in treating seasonal allergic rhinitis, and to identify the optimal dosage and a…
Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in a…
This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe…
The study is a multicenter, randomized, double-blind, placebo-controlled seamless and adaptive-designed phase IIb/III study encompassing a phase IIb and a phase…